Related Experiment Video
Updated: Jul 16, 2026

A Video Protocol of a Randomized Controlled Clinical Trial - Electrochemotherapy of Cutaneous Metastases with Reduced Dose Bleomycin (BLESS Trial)
Published on: June 9, 2026
Emerging treatment modalities: balancing efficacy and safety.
1Department of Anesthesiology, Thomas Jefferson University Hospital, Philadelphia, PA 19107, USA. eugene.viscusi@fefferson.edu
New pain management strategies offer improved options for post-operative pain relief. While intravenous patient-controlled analgesia (i.v. PCA) and epidural analgesia have drawbacks, emerging treatments show promise for better patient outcomes.
Area of Science:
- Anesthesiology
- Pharmacology
- Pain Management
Background:
- Post-operative pain management remains a critical aspect of patient recovery.
- Traditional methods like intravenous patient-controlled analgesia (i.v. PCA) and epidural analgesia present challenges.
- These challenges include complexity, potential for errors, and variable efficacy.
Purpose of the Study:
- To discuss the advantages and disadvantages of i.v. PCA and epidural analgesia.
- To explore novel approaches for managing acute post-operative pain.
- To present findings from controlled clinical trials evaluating these pain management modalities.
Main Methods:
- Review of existing literature and controlled clinical trials.
- Comparative analysis of i.v. PCA and epidural analgesia.
- Discussion of emerging analgesic agents and technologies.
Main Results:
- Intravenous patient-controlled analgesia (i.v. PCA) is effective but complex, requiring significant staff and posing risks of programming errors.
- Epidural analgesia has a high failure rate and requires substantial staff intervention.
- Extended-release epidural morphine showed a 48-hour duration and reduced need for supplemental analgesia in hip arthroplasty.
- Fentanyl Iontophoretic Transdermal System demonstrated equivalence to i.v. PCA with similar safety.
- Selective opioid antagonists targeting gastrointestinal receptors are under development.
Conclusions:
- Current pain management techniques have limitations.
- Newer agents and technologies show potential to address unmet needs in post-operative pain management.
- Advancements aim to improve efficacy, safety, and patient experience.
Related Concept Videos
Drug Therapy
Antianxiety Medications
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Pharmaceutical Poisoning: Treatment Strategies
Dosage Regimen: Individualization